Search Tag: Lung

2019 30 Aug

Acute Respiratory Distress Syndrome (ARDS) affects up to 10% of patients in the ICU. Typical symptoms of ARDS include an increase in lung weight and a reduction of aerated lung tissue. For the treatment of ARDS alveolar recruitment is key, however, this has not yet been shown to benefit severe ARDS cases. It has been suggested that lung recruitment...Read more

2018 07 Nov

Ventilator-induced lung injury is a multifaceted problem that has progressively become a preoccupation for intensivists and anaesthesiologists. Interestingly, it has taken many years to realise that mechanical ventilation, a life-saving technique, could also induce harm, according to an Editorial article published online in the journal Anesthesiology....Read more

2017 12 Apr

The dramatic story of Canadian Melissa Benoit, who lived for six days without a lung, shows a view of a new chapter in the history of medical technology. The novalung iLA membrane lung, which replaced the functions of the lung, is a product of XENIOS AG. As a strategic partner of XOR Labs in Toronto, both companies wanted to cooperate to revolutionize...Read more

2016 14 Jan

A new study shows that exposure to higher daily levels of ozone is associated with development of acute respiratory disease syndrome (ARDS) in critically ill patients, particularly in trauma patients and current smokers. The findings, reported in the American Journal of Respiratory and Critical Care Medicine , indicate that ozone exposure may represent...Read more

2015 30 Jan

An experimental work shows for the first time the utility of the stress index to adjust in real time artificial ventilation supply in order to avoid lung injuries. Results of the study are published in the journal Critical Care . The research work was led by Professor Francisco Javier Belda, Head of the Department of Anaesthesia and Intensive Care...Read more

2014 18 Mar

MAQUET and Swisstom are pleased to announce their distribution partnership for the monitoring and diagnostic product Swisstom BB2 Acute Lung Injury is still a leading cause of death for intensive care patients. Swisstom BB2 was especially developed to continuously monitor lung function of ICU patients undergoing mechanical ventilation. It offers...Read more

2014 10 Mar

The amount of patients having undergone lung transplantations has increased by roughly 20% over the past five years. For those suffering during the end stage of various lung diseases, transplantation can provide a prolongation and quality improvement of life as the last remaining treatment option. Marc Hartert and his team of colleagues have...Read more

2013 03 Oct

A Yale-led study has identified a gene expression profile that can predict outcomes and lead to better treatment for one of the most lethal lung diseases, idiopathic pulmonary fibrosis (IPF). The study appears in Science Translational Medicine. IPF causes progressive scarring of the lungs, leading to cough, shortness of breath, and potentially death....Read more

2013 14 Aug

Johns Hopkins-led research finds larger lungs associated with 30 percent increase in survival at one year. Transplant teams have long tried to match the size of donor lungs to the size of the recipient as closely as possible, concerned that lungs of the wrong size could lead to poor lung function and poor outcomes. But new Johns Hopkins-led research...Read more

2013 04 Jun

Covidien, a leading global provider of healthcare products, announced on May 21, 2013 that its superDimension Electromagnetic Navigation Bronchoscopy (ENB™) system, the first technology of its kind, is included in the new American College of Chest Physicians (ACCP) guidelines to aid in diagnosing and managing lung cancer. The evidence-based clinical...Read more

2013 29 May

Most lung cancers are detected when patients become symptomatic and have late-stage disease. However, recently, computed tomography (CT) screening for lung cancer has been reported to reduce lung cancer mortality. Since the National Lung Screening Trial’s results showed a 20 percent reduction in lung cancer-specific deaths in those patients who had...Read more

2013 09 Mar

Scientists at the Vall d´Hebron Institute of Oncology (VHIO) in Barcelona, Spain, report that they have eradicated lung tumours in a pre-clinical mouse model. Previous studies had already shown that Myc was a key protein in tumour development and had established how to inhibit Myc through gene therapy. This protein is involved in the development...Read more